La recherche sur la pratique pharmaceutique gagne en dynamisme et en profondeur
I t's a coincidence that one name crops up on three other pages of this issue of CPJ, but it's hardly a random accident.
Ross Tsuyuki is a contributor to CPJ (and not for the first time). He is a coauthor on a paper (p. 33) that describes and analyzes how physicians responded to community pharmacists in a project on cardiac health. This innovative research project (Study of Cardiovascular Risk Intervention by Pharmacists, or SCRIP) developed a model for enhancing cardiovascular care through pharmacist participation.
Since the first paper from the study was published in Archives of Internal Medicine in 2002, SCRIP has become something of a gold standard in the burgeoning field of researching the practice of pharmacy. SCRIP's topic, project protocol and study design, and implications are resonating throughout the field of pharmacy research. Any project of SCRIP's magnitude generates a host of results and potential papers, and we are proud to bring you this piece of the SCRIP publishing mosaic.
Meanwhile, this month's issue includes items on CPhA's 2004 award winners. The CPJ team was thrilled -but not surprised -to learn that Ross has been named Pharmacist of the Year. Learn more about the leadership that he provides to the profession (p. 24).
Finally, his name appears on the CPJ masthead as chair of our editorial board. When he agreed to serve in this capacity we were excited for the same reason that he was nominated for the CPhA award: what better person to help shape a vision for CPJ than someone who has emerged as a model and key opinion leader across a wide spectrum of practice and research? (And if you're wondering whether this paper went through the same blinded peer review process as any other submission, the answer is yes.)
One theme that emerged in the editorial board's reflection in the past year is that, as SCRIP itself exemplifies, the ground in pharmacy research is shifting. Even a decade ago, research in pharmacist interventions was new and exciting, while struggling to make a mark. (CPhA members played an important role by supporting the position of research director, held by Jeff Poston [now CPhA's Executive Director] and more recently, Kirsten Woodend [also a coauthor in this issue], and the newly appointed Angela Todd.) All that is changing, as pharmacy practice research has gained tremendous momentum. The volume and quality has expanded and deepened, both in the academic stream and in engagement with participating community and hospital pharmacists. The fact that this CPJ also includes research papers on reimbursement strategies and pharmaceutical care demonstrates some of that vigour and scope.
CPJ intends to bring the best of pharmacy practice research to pharmacists across Canada, to engage pharmacists in that research, and foster a dialogue on its implications. Stay tuned… ■ -Polly Thompson, Editor pthompson@pharmacists.ca L e fait qu'un même nom paraisse dans trois autres pages du présent numéro de la RPC s'avère peut-être une coïncidence, mais rarement le fruit du hasard.
Ross Tsuyuki figure parmi les collaborateurs de la RPC (et dans son cas, il ne s'agit pas d'une première). Il a corédigé un article (p. 33) faisant la description et l'analyse de la réac-tion d'un groupe de médecins à l'intervention de pharmaciens communautaires dans le cadre d'un projet sur la santé cardiaque. Ce projet novateur (baptisé SCRIP, acronyme de Study of Cardiovascular Risk Intervention by Pharmacists) a permis d'élaborer un modèle de perfectionnement du traitement des maladies cardiovasculaires, grâce à la partici-pation des pharmaciens.
Depuis la parution du premier article sur cette étude dans Archives of Internal Medicine, en 2002, le projet SCRIP est devenu, pour ainsi dire, la norme par excellence dans le domaine de la recherche sur la pratique pharmaceutique, qui connaît un essor remarquable. Le sujet de cette Suite à p. 9
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